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Exercise induces physiological cardiac growth and
protects the heart against pathological remodeling.
Recent work suggests exercise also enhances the
heart’s capacity for repair, which could be important
for regenerative therapies. While microRNAs are
important in certain cardiac pathologies, less is
known about their functional roles in exercise-
induced cardiac phenotypes.We profiled cardiacmi-
croRNAexpression in twodistinctmodels of exercise
and foundmicroRNA-222 (miR-222) was upregulated
in both. Downstream miR-222 targets modulating
cardiomyocytephenotypeswere identified, including
HIPK1 and HMBOX1. Inhibition of miR-222 in vivo
completely blocked cardiac and cardiomyocyte
growth in response to exercise while reducing
markers of cardiomyocyte proliferation. Importantly,
mice with inducible cardiomyocyte miR-222 expres-
sion were resistant to adverse cardiac remodeling
and dysfunction after ischemic injury. These studies
implicatemiR-222 as necessary for exercise-induced
cardiomyocyte growth and proliferation in the adult
mammalian heart and show that it is sufficient to
protect the heart against adverse remodeling.
INTRODUCTION
Heart failure is a growing cause of morbidity and mortality
throughout the world and often develops after a period of
abnormal growth termed pathological hypertrophy. Loss of car-
diomyocytes contributes to decreased cardiac function and
heart failure. While the heart has some regenerative capacity,
little is known about what regulates this ability or whether it584 Cell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc.can be effectively harnessed to mitigate these processes.
Thus, understanding the pathways that promote cardiomyocyte
survival and/or regeneration could have important fundamental
and clinical implications.
Many pathways have been implicated in heart disease, but
less is understood about what keeps the heart healthy. Clinical
and experimental studies document the impact of exercise in
both primary and secondary prevention of cardiovascular dis-
ease (Lim et al., 2012; Young et al., 2014). Prior work from our
groups utilized a genome-wide analysis to compare transcrip-
tional components involved in the exercise response versus
those involved in pathological hypertrophy after pressure over-
load (Bostro¨m et al., 2010). These studies demonstrated that ex-
ercise induces a transcriptional network distinct from that seen
with pathological stimuli, even at an early stage when the hearts
were structurally and functionally indistinguishable. In addition,
physiological growth was associated with transcriptional com-
ponents linked to cell-cycle progression, and exercised hearts
showed an increase in proliferation markers, specifically in
cells expressing cardiomyocyte sarcomere proteins (Bostro¨m
et al., 2010). These data suggested that exercise may provide
physiological cues that enhance the heart’s limited endogenous
capacity for regeneration, similar to effects that have been
documented in other organ systems, including the brain (van
Praag et al., 1999, 2005; Zhang et al., 2008). These studies
also implicated a transcriptional network regulated by C/EBPb
and CITED4, which appeared central to the cardiac exercise
response and protected the heart against adverse remodeling
(Bostro¨m et al., 2010).
MicroRNAs have been shown to regulate entire gene expres-
sion networks and play important roles in cardiovascular dis-
ease (Small and Olson, 2011). Although several studies have
examined microRNAs regulated by exercise (Care` et al.,
2007; DA Silva et al., 2012; Fernandes et al., 2011; Martinelli
et al., 2014; Soci et al., 2011), less is known about their func-
tional roles in this context. To identify microRNAs that are
differentially regulated and functionally important in exercised
hearts, we examined cardiac expression of all known mouse
microRNAs in two distinct models of endurance exercise.
Concordant changes were identified and validated before
screening for functional effects in cardiomyocytes in vitro.
Here we report that cardiac miR-222 is upregulated robustly
in both exercise models and induces cardiomyocyte hypertro-
phy and proliferation in vitro through effects on the cycle inhib-
itor p27, as well as HIPK1 and HMBOX1, acting upstream of
CITED4. miR-222 was necessary for exercise-induced cardiac
growth in vivo, and genetically mediated miR-222 expression
was sufficient to protect the heart against dysfunction and
adverse remodeling after ischemic injury.
RESULTS
Expression of miR-222 Is Induced during Physiological
Hypertrophy
To identify microRNAs that regulate physiological cardiac
growth, we subjected mice to either voluntary wheel running or
a ramp swimming exercise model (Taniike et al., 2008) for
3 weeks. As shown in Figures 1A–1D, both models induced
mild cardiac hypertrophy, and microRNAs were profiled in heart
samples from each exercise model in comparison to sedentary
controls using the TaqMan rodent miRNAarray (A+B set v3.0),
which includes 641 unique assays specific to mouse. Five
cardiac samples were used from mice exercised in each of the
models for 3 weeks in comparison to matched sedentary con-
trols. Fifty-fivemicroRNAswere differentially expressed in hearts
from swummicewhile 124were differentially expressed in hearts
from wheel-run mice, including 16 microRNAs that were concor-
dantly regulated and robustly validated in both models (Figures
1E–1F; Table S1).
The functional effects of all sixteen candidatemicroRNAswere
examined in cardiomyocytes in vitro using commercially avail-
able microRNA precursors. Since cardiomyocyte hypertrophy
is central to the acute growth of the heart in response to exercise,
we used a change in cell size as an endpoint for functional effects
(Figure S1A). In addition, our prior work had suggested exercise
could induce a proliferative response that might contribute to
cardiomyogenesis, and thus, we also examined incorporation
of the thymidine analog, EdU, in response to microRNA mimic
treatment (Figure S1B). As shown in Table S1, miR-222 emerged
as a particularly interesting candidate that was increased 2.1-
and 2.8-fold in the swimming and running exercise models,
respectively (p < 0.003 and 0.02). Studies in cardiomyocytes
and non-cardiomyocytes isolated from sedentary and exercised
hearts demonstrated that, after exercise, miR-222 increased in
adult cardiomyocytes (p < 0.05) but showed a non-significant
trend toward decreasing in non-cardiomyocytes (Figure 1G).
miR-222 was one of two microRNAs (along with miR-191) that
increased cardiomyocyte size in vitro and one of four (along
with miR-139, -27a, and -484) that increased EdU incorporation
(Figures S1A and S1B). Subsequent studies showed that only
miR-222, miR-339, andmiR-486 induced a physiological pattern
of myosin heavy-chain isoform expression (Figure S1C). Based
on the unique convergence of these functional characteristics
in cardiomyocytes in vitro and its exercise-induced increase
specifically in cardiomyocytes in vivo, miR-222 was selected
for more detailed study.CmiR-222 is a highly conserved member of a microRNA cluster
encoded on the X chromosome, which also includes miR-221
(Felli et al., 2005; Galardi et al., 2007). Although its function in
the heart is unknown, miR-222 has documented roles in regu-
lating cell proliferation and differentiation in vascular smooth
muscle cells and some cancers (le Sage et al., 2007; Liu et al.,
2009), at least in part through targeting the cell-cycle inhibitor
p27 (Kim et al., 2009; Liu et al., 2009; Wurz et al., 2010). Intrigu-
ingly, miR-222 has been reported to increase in the plasma of
athletes after both acute and chronic exercise (Baggish et al.,
2011), suggesting potential human relevance of our observa-
tions. Of note, expression of neither miR-221 in hearts nor
miR-222 in skeletal muscle was increased in our exercised
mice (data not shown).
miR-222 Increases after Exercise in Heart Failure
Patients
Since miR-222 has been reported to increase in the peripheral
blood of healthy young athletes after exercise (Baggish et al.,
2011) and exercise has beneficial effects in heart failure patients
(Flynn et al., 2009; O’Connor et al., 2009), we wondered whether
these observations could be related. As an initial step, we exam-
ined changes in circulating miR-222 in twenty-eight heart failure
patients after cardiopulmonary exercise testing using a bicycle
ergometer. Subjects included chronic stable heart failure
patients (NYHA Class II-IV) with both preserved and reduced
systolic function (Table 1). Exercise duration ranged from 2.5
to 11min on a standardized protocol (Myers, 2005). Interestingly,
circulating miR-222 increased 1.8-fold (p = 0.01) after exercise
(Figure 1H), a similar pattern to that seen in young athletes
(Baggish et al., 2011).
miR-222 Promotes Cardiomyocytes Growth,
Proliferation, and Survival In Vitro
Gain- and loss-of-function were used to examine miR-2220s
roles in neonatal cardiomycytes. Expression of miR-222 induced
an increase in cardiomyocyte size (Figure 2A). miR-222 expres-
sion also increased markers of cardiomyocyte proliferation and
cell number (Figure 2C). Conversely, a specific miR-222 antago-
mir inhibitor reduced cardiomyocyte size and proliferation (Fig-
ures 2B and 2D). In addition, miR-222 expression suppressed
while miR-222 inhibition increased cardiomyocyte apoptosis
induced by serumdeprivation alone or in combination with doxo-
rubicin (Figure 2E). Moreover, miR-222 induced a pattern of gene
expression in cardiomyocytes consistent with physiological
growth, including an increase in myosin heavy-chain (MHC)-
a/b ratio, as well as decreases in expression of ANP, BNP, and
a-skeletal actin mRNAs (Figure 2F). These data indicate that
miR-222 expression is sufficient to induce a complex pattern
of physiological growth in neonatal cardiomyocytes including
cellular hypertrophy and proliferation while inhibiting apoptosis.
miR-222 Regulates Growth and Proliferation of
Cardiomyocytes In Vitro through Targeting p27, HIPK1,
and HMBOX1
To identify the responsible downstream mechanisms for miR-
2220s effects in cardiomyocytes, we performed transcript
profiling on cardiomyocytes expressing miR-222 in comparison
to scrambled control. These data have been deposited inell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc. 585
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Figure 1. MicroRNAs Are Differentially Regulated by Exercise
(A and B) HW/BW and HW/TL ratios of sedentary control (control) and swum (swim) mice. n = 9 mice per group.
(C and D) HW/BW and HW/TL ratios of sedentary control (control) and voluntary wheel-running (run) mice. n = 4 mice per group.
(E) Heat map of 40 differentially regulated miRNAs concordantly altered in hearts from swimming and running mice compared to sedentary controls. n = 3 with
three mouse hearts per pool.
(F) qRT-PCR analysis of the identified 40 differentially regulated miRNAs in hearts from separate cohorts. n = 5 hearts per group.
(G) qRT-PCR analysis of miR-222 expression in isolated adult cardiomycytes and non-cardiomycytes from voluntary wheel-running mice. n = 4 mouse hearts
per group.
(H) qRT-PCR analysis of miR-222 levels in serum from heart failure patients before (con) and after acute exercise. Data are shown as fold-change of miR-222
expression normalized to spiked cel-miR-39. n = 28. *p < 0.05, #p < 0.05, and **p < 0.01 versus respective control using Student’s test. Data shown as
mean ± SEM.the Gene Expression Ommibus (GEO accession number:
GSE59641). Expression profiling revealed that miR-222 induced
an increase in Cited4 mRNA levels, indicating cross-talk
with the transcriptional pathway linked to exercise that we
reported earlier (Bostro¨m et al., 2010). In GO pathway analyses,
the most upregulated functional pathway was ‘‘Cell Cycle’’ (p <586 Cell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc.108). Comparison of expression profiling results with miR-222
targets predicted by two bioinformatic programs (Targetscan,
Pictar) identified four relevant potential targets whose expres-
sion decreased in cardiomyocytes with miR-222 expression.
These include the known target and cell-cycle inhibitor
p27(kip1) (Kim et al., 2009; Liu et al., 2009; Wurz et al., 2010)
Table 1. Patient Information
Heart Failure with
Reduced EF (HFrEF)
(EF < 55%)
Heart Failure with
Preserved EF (HFpEF)
(EFR 55%)
Number 19 9
Sex Male Male
Age (year) 56.71 ± 10.35 63.70 ± 16.28
BMI 26.32 ± 2.52 24.07 ± 2.34
EF (%) 39.37 ± 6.27 65.22 ± 5.54
NYHA Class 2.74 ± 0.45 2.00 ± 0
Values are mean ± SD.as well as three additional targets: the protein kinases HIPK-1
(Isono et al., 2006; Li et al., 2005) and -2 (D’Orazi et al., 2002)
and a transcriptional repressor, HMBOX1 (Chen et al., 2006).
Interestingly, genetic deletion of p27 induces cardiomyocyte
hyperplasia in vivo (Fero et al., 1996; Kiyokawa et al., 1996; Na-
kayama et al., 1996) and physiological cardiac hypertrophy
(Hauck et al., 2008) but accelerates the development of heart fail-
ure after biomechanical stress (Hauck et al., 2008). The other
three candidates (HIPK1, HIPK2, and HMBOX1) that we identi-
fied have no known roles in the heart.
miR-222 expression in cardiomyocytes in vitro was sufficient
to reduce expression of all four putative targets (p27, Hipk1,
Hipk2, and Hmbox1) from 35% to 55%, while a specific miR-
222 inhibitor increased their expression (Figure 3A). These
changes in RNA levels were paralleled by changes in protein
expression for each of the targets (Figure 3B). To determine
whether Hipk1, Hipk2, and Hmbox1 were direct targets of
miR-222, we cloned either their wild-type 30 UTRs or 30 UTRs
in which the putative miR-222 binding sites had been mutated,
downstream of a luciferase reporter. miR-222 had no effect
on luciferase activity of the control reporter without a miR-222
binding site (data not shown). miR-222 induced a reduction
in luciferase activity for each of the wild-type 30 UTR constructs
but, importantly, had no effect when the miR-222 binding
sites were mutated (Figure 3C). These data strongly suggest
that Hipk1, Hipk2, and Hmbox1 are each direct targets of
miR-222, as has been shown previously for p27 (Galardi et al.,
2007).
To determine how these targets contribute to miR-222’s
effects in cardiomyocytes, we used siRNA knockdown for
each target (Figure 3D) and examined effects on relevant cardi-
omyocyte phenotypes. siRNA knockdown of either p27 or HIPK1
was induced an increase in EdU incorporation (Figure 3E) and
the number of cardiomyocytes (Figure 3F). Hmbox-1 knockdown
did not affect cell number but increased cell size (Figure 3G).
Interestingly, p27 knockdown actually decreased cell size,
perhaps reflecting active cell division; HIPK2 had no significant
effect in either assay. These data imply that reductions in p27
and HIPK1 are sufficient to induce the proliferative effects of
miR-222 in cultured cardiomyocytes, while reduced Hmbox-1
likely contributes to the observed cellular hypertrophy. We then
examined whether miR-222 and its targets intersect with the
previously described pathway involving C/EBPb and CITED4.
Interestingly, siRNA knockdown of either p27 or Hmbox1 was
sufficient to increase CITED4 expression without altering C/CEBPb expression (Figures S2A and S2B). In contrast, simulta-
neous knockdown of p27 and HIPK1 did not signficantly alter
CITED4 expression and actually increased C/EBPb expression
(Figure S2C). Taken together, these data suggest that the miR-
222 pathway acts upstream of CITED4, but the combinatorial
effects of its targets in this regard are complex.
miR-222 Is Necessary for Exercise-Induced Cardiac
Growth
To investigate the role of miR-222 in the cardiac exercise
response, we injected mice with LNA-anti-miR-222 or scram-
bled control LNA-anti-miR for 3 days prior to exercise and then
weekly during the 3 week swim protocol. LNA-antimiR-222
decreased miR-222 expression in hearts from both sedentary
and exercised animals by R98% without affecting the expres-
sion of pre-miR-222 or the closely related miR-221 (Figure 4A).
Exercised but untreated animals showed an increase in cardiac
mass reflected in ratios of heart to body weight (HW/BW) or tibial
length (HW/TL), which were increased 21% and 15%, respec-
tively (p < 0.001 for both) compared to sedentary controls (Fig-
ures 4B and 4C). Treatment of sedentary animals for 3 weeks
with either the LNA-antimiR-222 or scrambled control antimiR
had no effect on HW/BW or HW/TL (Figures 4B and 4C). The
scrambled LNA-antimiR also did not affect exercise-induced
cardiac growth. However, the specific LNA-antimiR-222
completely blocked the increase in heart size inducedby 3weeks
of intensive exercise (Figures 4B and 4C). As noted earlier, short-
term changes in heart size are generally related to changes in
cardiomyocyte size and, indeed, examination of cardiomyocyte
size on WGA-stained sections revealed a similar pattern. Treat-
ment of sedentary animals for 3 weeks with LNA-antimiR-222
or scrambled control antimiR had no effect on cardiomyocyte
size (Figure 4D). Exercise increased cardiomyocyte size 20%
(p < 0.05) in untreated or control LNA-antimiR-treated mice (Fig-
ure 4D), while cardiomyocytes in swum mice treated with LNA-
antimiR-222 were no different in size from cardiomyocytes in
sedentary, untreated mice (p = NS). There was no significant dif-
ference in hypertrophic or fetal gene markers between hearts
from mice treated with the control or specific LNA-antimiR-222
(Figure S3A). Our prior work had suggested that exercise
increases proliferation markers in the cardiomyocyte lineage
(Bostro¨m et al., 2010), and indeed, a substantial increase in
both phospho-HistoneH3 (pHH3) and ki67 was again seen in
cardiomyocytes from exercised, untreated animals (Figures 4E
and 4F). This increase was not altered by the control antimiR
but was decreased, though not reduced to baseline, by LNA-
antimiR-222. Taken together, these data demonstrate that
miR-222 is necessary for the short-term growth of the heart
and cardiomyocytes in response to exercise. Although the
change in cardiomyocyte size appears to account for the change
in heart size over these short periods of time, it is interesting to
note that miR-222 also appears to contribute to the increase in
markers of proliferation seen in cardiomyocytes after exercise.
Whether these markers of proliferation reflect productive cardio-
myogenesis that has an impact over longer periods of time will
require long-term cell-fate-mapping experiments to address.
We next examined whether the targets identified in vitro were
regulated by exercise or LNA-antimiR-222 in vivo. Three weeks
of exercise decreased cardiac HMBOX1 and HIPK2 in miceell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc. 587
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Figure 2. miR-222 Regulates Cardiomyocyte Hypertrophy, Proliferation, and Apoptosis In Vitro
By using miR-222 gain- and loss-of-function in NRVMs, miR-2220s effects on cardiac cell size, proliferation, and hypertrophic markers were examined.
(A and B) Immunohistochemical staining for sarcomeric a-actinin followed by quantification of cardiomyocyte area as described in the Experimental Procedures.
Cells were transfected with control or miR-222 precursor in (A) and with control antimiR (ctl-anti) or antimiR-222 (anti-222) in (B). At least 200 cells were quantified
in each group. These data demonstrate miR-222 is necessary and sufficient to induce cardiomyocyte hypertrophy.
(C) Quantification of EdU and Ki67 staining, as well as cell number from primary NRVMs transfected with control precursor (ctl-pre) or miR-222 precursor
(pre-222).
(D) Quantification of EdU and Ki67 staining and cell number from NRVMs transfected with control antimiR (ctl-anti) or antimiR-222 (anti-222). These data
demonstrate miR-222 is necessary and sufficient to induce proliferation of NRVMs.
(E) Flow cytometry analysis of TUNEL staining in cardiomyocytes treated with control precursor (ctl-pre) or miR-222 precursor (pre-222) or control antimiR (ctl-
anti) or antimiR-222 (anti-222). Cardiomyocye apoptosis was induced by serum deprivation (SD) or serum deprivation plus doxorubicin (SD+doxorubicin). These
data demonstrate miR-222 inhibits cardiomyocyte apoptosis.
(F) qRT-PCR for markers of cardiomyocyte hypertrophy and/or pathology in NRVMs treated with control (ctl-pre) or miR-222 precursor (pre-222). These data
demonstrate that miR-222 induces a physiological pattern of gene expression. Data are shown asmean ± SEM fold-change of gene expression normalized to U6
and reflect at least three independent experiments. Scale bar: 100 mm. *p < 0.05 and **p < 0.01 versus respective control using Student’s test.treated with the control LNA-antimiR, while p27 or HIPK1 were
not significantly altered at this time point (Figure 4G). Treatment
of exercising mice with LNA-antimiR-222 increased protein
levels for both HMBOX1 and p27 in comparison to exercised
mice treated with control LNA-anitmiR (Figure 4G). LNA-anti-
miR-222 did not affect HIPK1 or 2 levels in exercised mice in
this assay.
miR-222 Protects against Cardiac Dysfunction after
Ischemic Injury
Since miR-222 specifically increases in cardiomyocytes from
exercised hearts, we created inducible (doxycycline-off) cardio-
myocyte-specific miR-222 transgenics (Tg-miR-222) (Figures
S4A–S4D) to investigate the in vivo effects of cardiomyocyte
miR-222 expression. Tg-miR-222 mice manifested doxycy-588 Cell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc.cline-regulated, cardiac-specific miR-222 expression that was
6.5-fold increased 4 weeks after removal of doxycycline from
chow (Figures S4A–S4C). The induced expression of miR-222
was specific to cardiomyocytes (Figure S4C). Interestingly,
Tg-miR-222 mice appeared grossly normal at baseline after
induction of cardiac miR-222 expression with normal heart size
and cardiac function (Figure S4E; Table S4). Expression of fetal
gene or hypertrophic markers was not significantly different after
miR-222 induction for 4 weeks (Figure S3B). Surprisingly, protein
expression of HIPK1 and 2, as well as p27 and HMBOX1, were
not significantly different in Tg-miR-222 at baseline (Figure S4F).
Thus, although miR-222 is necessary for growth of the heart
in response to exercise, cardiomyocyte miR-222 expression,
even at levels higher than those induced by exercise, is not suf-
ficient to recapitulate the exercised-heart phenotype.
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Figure 3. miR-222 Targets in Cardiomyocytes
(A and B) qRT-PCR and immunoblotting were used to analyze RNA and protein levels of the four putative miR-222 targets in neonate cardiomyocytes treated with
control precursor (ctl-pre), miR-222 precursor (pre-222), control antimiR (ctl-anti), or antimiR-222 (anti-222), respectively. Data are shown as fold-change in gene
expression normalized to U6 in (A). These data demonstrate that miR-222 decreases RNA and protein levels for all four targets in primary cardiomyocytes.
(C) Luciferase assays of COS7 cells co-transfected with control precursor (ctl-pre) or miR-222 precursor (pre-222) and reporter plasmids containing 30 UTR wild-
type or mutated miR-222 binding sites for each of the putative target genes. These data demonstrate all three candidates are direct targets of miR-222.
(D) Immunoblotting of the four genes in neonate cardiomyocytes transfected with control siRNA (ctl-si) or siRNAs of p27 (sip27), Hmbox1 (siHmbox1), Hipk2
(siHipk2), and Hipk1 (siHipk1) demonstrate effective knockdown for all. HSP90 was used as a loading control.
(E) Flow cytometry for EdU in neonate cardiomyocytes transfected with indicated siRNAs demonstrates that knockdown of p27 or HIPK1 increases EdU
incorporation in cultured cardiomyocytes, consistent with proliferation.
(F and G) Neonate cardiomyocytes cultures were stained for sarcomeric a-actinin to identify cardiomyocytes, and cardiomyocyte number and area were
quantified. Knockdown of p27 and HIPK1 increases cardiomyocyte proliferation (F) while HMBOX1 knockdown increases cardiomyocytes size (G). At least 200
cells or 30 images were quantified in each group. Data represent the mean ± SEM from at least three independent experiments. Scale bar: 100 mm. *p < 0.05 and
**p < 0.01 versus respective control using Student’s test.Exercise reduces adverse ventricular remodeling and cardiac
dysfunction when initiated after infarction in animal models (Ban-
sal et al., 2010; Wan et al., 2007; Xu et al., 2008, 2010; Yengo
et al., 2012) and humans (Haykowsky et al., 2011), attenuating
fibrosis, dilatation, and cardiac dysfunction. To assess the
possible protective role of miR-222 expression in this context,
Tg-miR-222 mice were withdrawn from doxycycline and then
subjected to ischemia-reperfusion injury (IRI) induced by
30min coronary ligation and reperfusion. One day after ischemic
injury, Tg-miR-222 mice showed no difference in initial infarct
size or degree of cardiac dysfunction compared to controls
(Figures 5A and 5B). However, while control mice showed the
progressive ventricular dilation and decline in cardiac functionCknown as adverse remodeling, Tg-miR-222 mice did not but
maintained both chamber dimension and cardiac function (Fig-
ure 5B). Six weeks after ischemic injury, miR-222-expressing
mice had better function (Figure 5B) and a 70% reduction in car-
diac fibrosis (Figure 5C). Interestingly, in vivo miR-222 expres-
sion after ischemic injury was associated with EdU incorporation
that was increased in cardiomyocytes but decreased in non-
cardiomyocytes, which are predominantly fibroblasts (Fig-
ure 5D). Another marker of proliferation, pHH3, was increased
2-fold in cardiomyocytes in hearts of miR-222-expressing mice
compared one week after ischemic injury controls (Figure 5E).
In contrast, cardiomyocyte apoptosis was reduced 3-fold in
hearts of miR-222-expressing mice at the same time-pointell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc. 589
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Figure 4. miR-222 Is Necessary for Exercise-Induced Cardiac Growth
(A) Sedentary or swum mice were intravenously injected with LNA-antimiR-222 or control LNA-antimiR for 3 weeks prior to quantification of cardiac miR-222 to
demonstrate effective reductions of mature miR-222 not pre-miR-222.
(B and C) HW/BW and HW/TL ratios are shown from sedentary control (sed, n = 15) and swum (swim, n = 16) mice without injection, sedentary mice injected with
control LNA-antimiR (sed ctl-anti, n = 7) or LNA-antimiR-222 (sed anti-222, n = 7), and swum mice injected with control LNA-antimiR (swim ctl-anti, n = 7) or
LNA-antimiR-222 (swim anti-222, n = 6). These studies demonstrate that LNA-antimiR-222 completely blocks cardiac hypertrophy in response to swimming.
(D) Quantification of cardiomyocyte area from heart sections stained with wheat germ agglutinin (WGA) (n = 5 to 6, 500 cells per animal) demonstrate that
LNA-antimiR-222 also blocks exercise-induced cardiomyocyte hypertrophy.
(E and F) Immunohistochemical staining for phospho-histoneH3 (pHH3) (E) and Ki67 (F) from heart sections and quantification (n = 5 to 6 hearts in each group)
demonstrates that LNA-antimiR-222 reduces markers of cardiomyocyte proliferation.
(G) Western blot results show the effect of LNA-antimiR-222 on miR-222 targets in hearts after exercise. Scale bar: 100 mm in (D) and 50 mm in (E) and (F). Error
bars stand for SEs. *p < 0.05, versus sed ctl-anti or sedentary control; #p < 0.05 versus swim ctl-anti using one-way ANOVA.(Figure 5F). There was no significant difference in expression of
hypertrophic markers 1 week after ischemic injury (Figure S3C).
Taken together, these data demonstrate that miR-222 is suffi-
cient to mitigate adverse remodeling after ischemic injury, pre-
serving cardiac structure and function while reducing late scar
formation after ischemic injury.
We examined the targets identified in vitro in transgenic and
control animals 1 week after ischemic injury. Interestingly, pro-
tein expression of all four targets was significantly reduced in
Tg-miR-222 hearts after ischemic injury (Figure 5G). These
data are consistent with the hypothesis that one or more of these
targets could contribute to the protection observed in vivo. How-
ever, establishing such a causal link will require future studies as-
sessing their in vivo functional contributions, individually and/or
in combination.
DISCUSSION
Despite a wealth of evidence supporting the cardiovascular ben-
efits of exercise, the mechanisms responsible, particularly in the
heart, remain poorly understood. MicroRNAs have emerged as590 Cell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc.central regulators of cardiac gene expression and key partici-
pants in a variety of cardiac pathologies (Small and Olson,
2011). Others have also examined microRNAs that are dynami-
cally regulated by exercise (Care` et al., 2007; DA Silva et al.,
2012; Fernandes et al., 2011; Martinelli et al., 2014; Soci et al.,
2011), although less is known about their functional roles in exer-
cise or their ability to mitigate cardiac pathologies. Here we pro-
vide evidence for a cardiac pathway induced by exercise and
mediated by miR-222 that appears important in both. miR-222
was necessary for exercise-induced growth of cardiomyocytes
and overall heart size. Interestingly, while miR-222 expression
was not sufficient to recapitulate the cardiac exercise phenotype
at baseline, it did protect against adverse ventricular remodeling
and cardiac dysfunction after ischemic injury. Moreover, these
effects were associated with inhibition of cardiomyocyte
apoptosis as well as a dramatic decrease in fibrosis late after
ischemic injury. Since miR-222 expression also protected iso-
lated primary cardiomyocytes from cell death and miR-222
expression in Tg-miR-222 mice is cardiomyocyte specific, it
seems likely that improved cardiomyocyte survival is a primary
contributor to the benefits observed and that reduced fibrosis
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Figure 5. Cardiac-Specific Expression of miR-222 Protects against Cardiac Remodeling and Dysfunction after Ischemic Injury
(A) Tiphenyltetrazolium chloride (TTC) staining to delineate infarct area and fluorescent microsphere distribution to define the AAR in hearts from tTA single
(miR-222-/tTA+) and double transgenic (miR-222+/tTA+) mice, 24 hr after reperfusion after ischemia, demonstrate no difference in initial infarction in miR-222-
expressing hearts. Representative photographs of TTC staining and fluorescentmicrosphere distribution (bottom) ofmedial sections of cardiac tissues are shown
(n = 6 to 7 in each group). Scale bar: 1,000 mm.
(B) Cardiac fractional shortening and left ventricular internal dimension in systole (LVIDs) asmeasured by transthoracic echocardiography in tTA single (miR-222-/
tTA+) and double transgenic (miR-222+/tTA+) mice at baseline, 24 hr, or 6 weeks after ischemic injury (n = 8 to 9 mice in each group). These data demonstrate
similar cardiac dysfunction at 24 hr but better function and less dilation in miR-222-expressing hearts at 6 weeks.
(C) Masson trichrome staining (n = 6 to 7 hearts in each group) demonstrates less fibrosis in miR-222-expressing double transgenic hearts at 6 weeks after
ischemic injury. Scale bars are shown.
(D and E) Immunofluorescence demonstrates increased EdU incorporation in cardiomyocytes in miR-222-expressing hearts 6 weeks after ischemic injury but
reduced EdU incorporation in non-cardiomyocytes (n = 5 animals in each group, 2,500 cells counted per animal) (D) and marker of cardiomyocyte proliferation
phospho-histoneH3 (pHH3) increases in miR-222-expressing hearts 1 week after ischemic injury in cardiomyocytes (n = 4 hearts in each group) (E).
(F) TUNEL staining demonstrates reduced apoptosis in cardiomyocytes in miR-222-expressing hearts 1 week after ischemia injury (n = 4 hearts in each group).
(G) Immunoblotting shows reduced expression of HIPK1, HIPK2, HMBOX1, and p27 in miR-222-expressing hearts 1 week after ischemic injury (n = 4 hearts in
each group). Scale bar: 100 mm. Data shown as mean ± SEM. *p < 0.05 and **p < 0.01 versus respective control using Student’s test.(and fibroblast proliferation) is secondary to this. However,
additional contributions from paracrine cross-talk cannot be
excluded based on these studies.
The short-term growth of the heart in response to exercise ap-
pears to occur primarily through changes in cardiomyocyte size.
Indeed, the inhibition of exercise-induced cardiac growth by
LNA-antimiR-222 corresponded well with inhibition of cardio-
myocyte hypertrophy. Thus, the increased markers of cell prolif-
eration, specifically in the cardiomyocyte lineage, seen here with
exercise, as in previous reports from our own groups (Bostro¨mCet al., 2010) and others (Waring et al., 2014) are unlikely to
have an important impact over the short time periods examined.
Moreover, markers of proliferation alone cannot establish
whether exercise stimulates an increase in cardiomyogenesis.
Multiple lines of evidence suggest the heart has some endoge-
nous capacity for repair (Bergmann et al., 2009; Bersell et al.,
2009), and exercise has been reported to enhance endogenous
regeneration in other organ systems such as the brain (van Praag
et al., 1999, 2005; Zhang et al., 2008). However, unambiguously
demonstrating whether exercise can do similar things in theell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc. 591
heart will require long-term cell-fate-mapping experiments.
Nevertheless, we believe this hypothesis is worth pursuing, since
identifying and learning to exploit pathways regulating this
response in the heart could have important implications for the
treatment of a range of cardiac diseases.
Surprisingly, although miR-222 was necessary for exercise-
induced cardiac growth, miR-222 expression—even at levels
higher than those induced by exercise—was not sufficient to
induce an increase in heart size at baseline or changes in its tar-
gets. Interestingly, after ischemic injury, miR-222 had important
protective phenotypic effects that correspondedwith reductions
in all four targets. Two general models could contribute to this
observation. Since LNA-antimiR-222 inhibits miR-222 in all line-
ages, perhaps miR-222 expression in other lineages is also
important in exercise-induced cardiac growth. Arguing against
this explanation, we found that exercise increased miR-222 spe-
cifically in cardiomyocytes, and the Tg-miR-222 mice have miR-
222 expression in non-cardiomyocytes and non-cardiac tissues
similar to controls. A second and intriguing possibility is thatmiR-
222 is necessary but not sufficient because other signals—
acting in cardiomyocytes—are needed in concert to recapitulate
the growth response. For example, sixteen cardiac microRNAs
were dynamically regulated by exercise andmultiple altered car-
diomyocyte size and proliferation. Future studies examining their
combinatorial effects would be of great interest. In addition, mi-
croRNA effects can be regulated by a variety of binding proteins
(Hammell et al., 2009; King et al., 2014), and it is possible that
interactions with such regulators inhibit miR-222’s effects at
baseline, but this inhibition is released in response to a second
stimulus, such as ischemic injury.
The current studies did not examine whether miR-222 affects
pathological hypertrophy, for example in response to pressure
overload. Previous work by others has suggested that some
physiological growth pathways (e.g., Akt1) are activated in
both settings but actually required for physiological growth and
antagonistic to pathological growth (DeBosch et al., 2006). The
models presented here will provide useful tools for testing
whether miR-222 functions in a similar way.
A combination of experimental and bioinformatic approaches
identified four candidate miR-222 targets in cardiomyocytes
in vitro. These included the cell-cycle inhibitor, p27, a known
target in other systems (Kim et al., 2009; Liu et al., 2009; Wurz
et al., 2010), and three other targets: HIPK-1 and -2 (D’Orazi
et al., 2002) as well as Hmbox1 (Chen et al., 2006). Luciferase as-
says confirmed that all are direct targets of miR-222 in vitro.
Moreover, functional studies in cardiomyocytes suggested that
reductions in p27 and HIPK1 contribute to the pro-proliferative
effects of miR-222 in vitro while decreased Hmbox1 is sufficient
to drive cardiomyocyte hypertrophy. Thus, the phenotypic ef-
fects of miR-222 appear mediated via distinct pathways and
may, in principle, be dissociable. Consistent with this model, ge-
netic deletion of p27 induces cardiomyocyte hyperplasia in vivo
(Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996)
and physiological cardiac hypertrophy (Hauck et al., 2008). How-
ever, in contrast to our results, p27 deletion accelerates the
development of heart failure after biomechanical stress (Hauck
et al., 2008). In comparison, the distinctly beneficial effects
seen with miR-222 expression likely reflects the combination of
less complete reduction in p27 and simultaneous modulation592 Cell Metabolism 21, 584–595, April 7, 2015 ª2015 Elsevier Inc.of other pathways. HIPK2 knockdown did not significantly affect
either cardiomyocyte size or proliferation in vitro, and under-
standing the role of HIPK2 in this context will be of interest
for future experiments. While all four putative targets were
decreased in vivo by miR-222 expression after ischemic injury,
we were only able to document modulation of two targets with
exercise (Hmbox1 and HIPK2) or LNA-antimiR-222 (Hmbox1
and p27) in vivo. It’s unclear whether these differences relate
to technical aspects of the experiments or the stronger signal
provided in the transgenic system.More importantly, while these
studies provide some support for modulation of the putative tar-
gets in vivo, they do not test their functional roles, which would
require additional gain- and/or loss-of-function studies for
each in vivo.
Finally, the potential clinical relevance of this pathway is
underscored by prior observations that circulating miR-222
increases in healthy volunteers after exercise (Baggish et al.,
2011) and our finding of a similar increase in heart failure pa-
tients. Of course, these studies neither establish a mechanistic
link between miR-222 and the cardiovascular benefits of exer-
cise in humans nor demonstrate that the heart is the source of
circulating miR-222, although miR-222 did not increase in skel-
etal muscle of exercised mice (data not shown). Future studies
examining the clinical implications of miR-222 as a biomarker
or functional mediator would obviously be of considerable
interest.
EXPERIMENTAL PROCEDURES
Please also see Supplemental Information for additional information on exper-
imental procedures.
Cardiomyocyte Isolation, Culture, and Transfection
Primary neonatal rat ventricular cardiomyocytes (NRVMs) were prepared as
described (Matsui et al., 2001). Isolated NRVMs were purified either by Percoll
gradient centrifugation (first two graphs of Figures 2C and S1) or by pre-plating
(all other experiments). Before treatment, NRVMs were synchronized and
cultured in serum-free (first two graphs of Figures 2C and S1) or 0.2% FBSme-
dia (all other experiments). DMEM medium was used for experiments except
DMEM/F12 for cell size experiments. siRNAs for p27(kip1), Hmbox1, Hipk1,
and Hipk2 and negative controls as well as microRNA precursors (Pre-miR
miRNA Precursors) and negative controls were purchased from Invitrogen.
Transfection of siRNAs (20 mM), LNA-modified antimiR oligonucleotides
(20 mM), and microRNA precursors (0.4 mM) were carried out using Lipofect-
amine RNAiMAX (Invitrogen) as recommended by the manufacturer.
Cardiomyocytes and non-cardiomyocytes were isolated from adult mice as
described previously (Graham et al., 2013). Briefly, left ventricles were har-
vested from perfused and digested hearts and dissected into small pieces
to dissociate in transfer buffer. After filtering, cell solution was settled to sedi-
mentation for several minutes in a Falcon tube. The cell pellet and supernatant
were transferred to individual Falcon tubes for further separation. The cell pel-
let was resuspended in transfer buffer and settled to precipitation. After the
second precipitation, the cell pellet was checked for typical rod-shaped
morphology before RNA and miRNA extraction to confirm expression of cardi-
omyocyte markers. The initial supernatant was centrifuged first at 50 3 g
(3 min) and then 300 3 g (5 min) before confirmation of non-cardiomyocyte
identity of pelleted cells by QRT-PCR for fibroblast and cardiomyocyte
markers.
Mouse Exercise Protocols
All mice were maintained and studied using protocols approved by the Animal
Care and Use Committee of Beth Israel Deaconess Medical Center. For forced
exercise training, male C57BL6/J mice swam in water tanks as described
(Taniike et al., 2008). Twenty-four hours after the last swimming session,
exercised mice were sacrificed and tissues were collected. For voluntary ex-
ercise, male C57BL6/J mice aged 10–12 weeks were housed with exercise
wheels as previously described (Bourajjaj et al., 2008). Mice were sacrificed
at the specified time-points, and tissues were harvested for analysis.
Generation of Tg-miR-222 Mice
A tetracycline-off binary a-MHC transgene system was used as previously
described (Sanbe et al., 2003). For the responder mouse line, a 388 bp frag-
ment containing mmu-miR-222 was amplified from mouse genomic DNA,
confirmed by sequencing and subcloned into a vector generously given by
Dr. Jeffrey Robbins. A Not I fragment was microinjected into FVB oocytes
and transferred to pseudopregnant mice. After confirmation of stable Mende-
lian transmission, positive mice were bred to the appropriate driver line (Sanbe
et al., 2003) and cardiac-specific, doxycycline-regulated miR-222 expression
was confirmed in line 12, which was used for all the experiments presented.
Doxycycline was administered in the food using a special diet formulated by
Purina (625 mg/kg in pellets). To induce miR-222 expression, 10- to12-
week-old mice were fed normal chow without doxycycline for 4 weeks.
LNA-antimiR Injections
LNA-antimiR injections were performed as described (Grueter et al., 2012).
Briefly, 12-week-old C57Bl6 male mice at baseline or used for swimming
training were injected subcutaneously or via tail vein with 10 mg/kg of locked
nucleic acid (LNA)-modified antimiR-222 (LNA-antimiR-222) or scrambled
control (LNA-SC) reconstituted in saline. Both LNA-antimiR oligonucleotides
were purchased from Exiqon. The sequence of LNA-antimiR-222
is +g*t*+a*+g*c*+c*a*+g*+a*t*+g*+t*a*g*+c, in which the ‘‘+’’ and ‘‘*’’ signs
indicated an LNA residue and the modified phosphorothioate linkages,
respectively. Mice were injected for three consecutive days and then weekly
throughout the experiments.
Ischemia Reperfusion Model and Analyses
Transgenic FVB mice were subjected to ischemia reperfusion as previously
described (Matsui et al., 2002). Briefly, the left anterior descending artery
(LAD) was ligated with 7-0 silk. Five minutes into ischemia, 50 ml of fluores-
cent microspheres (10 mm FluoSpheres, Molecular Probes) were injected into
the LV cavity. Following 30 min LAD occlusion, the LAD ligature was
released, and reperfusion was confirmed visually. After 24 hr, 1 weeks, or
6 weeks of reperfusion, mice were sacrificed, and hearts were collected
for analyses. To determine the area-at-risk (AAR) and myocardial infarct
size, hearts were stained with 2,3,5-triphenyltetrazolium chloride (TTC) as re-
ported previously (Matsui et al., 2002). In animals euthanized 6 weeks after
IRI, EdU (50 mg/kg, subcutaneously) was injected every 2 days for the first
2 weeks after reperfusion. Sham-operated mice served as controls. All sur-
geries and analyses were performed by investigators blinded to genotype
or treatment.
Microscopy, Confocal Microscopy, and Image Quantification
Images of cultured cells were taken in a Leica DM 5000 B microscope. Heart
sections were imaged in a Zeiss LSM 501 Meta confocal microscope using
standard procedures. All imaging was performed and analyzed by investiga-
tors blinded to treatment group. At least 30 random images were obtained
from each group. Images were then were quantified using ImageJ and
CellProfiler software.
Echocardiography
Echocardiography was performed on conscious mice by using a GE Vivid7
with i13L probe (14 MHZ) as described previously (Das et al., 2012). Briefly,
parasternal long-axis views, short-axis views, and 2D guided M-mode images
of short axis at the papillary muscle level were recorded. Echocardiography
data were analyzed by investigators blinded to treatment and genotype. The
average of at least three measurements was used for every data point from
each mouse.
Heart Failure Patients
All human investigation conformed to the principles outlined in the Declaration
of Helsinki and was approved by the relevant institutional review committees
(either Shanghai Tongji Hospital, Tongji University and/or Shanghai University).CAll participants gave written informed consent before enrollment in the study.
Between September 2013 andMarch 2014, twenty-eight patients with chronic
stable heart failure cared for at the Shanghai Tongji Hospital, Tongji University,
underwent a symptom-limited cardiopulmonary exercise test on a bicycle
ergometer (GE) using a standardized exercise protocol of revised Ramp10
programs (Myers, 2005). Venous blood was collected in serum tubes before
and after the cardiopulmonary exercise test and was processed within 1 hr
of collection. After a two-step centrifugation (820 3 g for 10 min and
16,000 3 g for 10 min, both at 4C), the supernatant was transferred to
RNase/DNase-free tubes and stored at 80C until RNA isolation and PCR
were performed as described before.
Statistical Analysis
Data are presented as mean ± SE unless otherwise indicated. Unpaired, two-
tailed Student’s t test was used when indicated with p < 0.05 considered sig-
nificant. When assessing multiple groups, one-way ANOVA was utilized with
Tukey’s post hoc test. The statistical software used was SPSS 17.1.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, four tables, and Supplemental
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